Better Context Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

Posted in: Glucose Monitoring, Insulin Delivery, Other Nov 28 | 2022Libre 3 + Ypsomed AID Authorized in Germany; Diamyd Ph3 T1DM Clinical Hold LiftedPurchase Blast
Posted in: Glucagon, Insulin Delivery, Other, SGLT2i Nov 11 | 2022AZ and Zealand Q3 ’22 Earnings Updates; Novo Smart Pen Integration with LibrePurchase Blast
Posted in: Basal Insulin, GLP-1RA, GLP-1RA + Basal, Other Nov 03 | 2022Novo Q3 ’22 London EarningsPurchase Blast
Posted in: Basal Insulin, GLP-1RA, Other Nov 02 | 2022Novo Nordisk Q3 ’22 Earnings Update; FY Guidance RaisedPurchase Blast
1 2 3 72

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.